Septerna Rings the Nasdaq Stock Market Opening Bell
Septerna (Nasdaq: SEPN), a biotechnology company discovering and advancing novel, oral small molecule medicines targeting G protein-coupled receptors (GPCRs), visits the Nasdaq MarketSite in Times Square to celebrate the company’s initial public offering. In honor of the occasion, Dr. Jeffrey Finer, Chief Executive Officer and Co-Founder of Septerna, rings the Opening Bell.